United Therapeutics

Acceleron’s post-Reblozyl plan comes together
EP Vantage
Tue, 01/28/20 - 11:09 am
Acceleron
sotatercept
PAH
JNJ
Bellerophon Therapeutics
United Therapeutics
Vivus
Arena
Novartis
Upcoming events – United seeks a Distinct hit, and Biogen nears a rare catalyst
EP Vantage
Fri, 08/9/19 - 10:26 am
United Therapeutics
Unituxin
SCLC
Biogen
MAb BIIB092
United Therapeutics Fires Back After Sandoz Files Anti-Competitive Lawsuit Over PAH Drug
BioSpace
Fri, 04/19/19 - 05:53 pm
United Therapeutics
PAH
Remodulin
generics
Sandoz
United Therapeutics tosses out esuberaprost after trial flop
Fierce Biotech
Mon, 04/8/19 - 09:59 am
United Therapeutics
PAH
esuberaprost
clinical trials
Arena’s Comeback Continues with $800M Deal for Blood Disease Drug
Xconomy
Thu, 11/15/18 - 11:41 pm
Arena Pharmaceuticals
United Therapeutics
PAH
ralinepag
Struggling MannKind sees shares rocket up on $105M-plus alliance with United on inhaled treprostinil
Endpoints
Tue, 09/4/18 - 09:43 am
MannKind
United Therapeutics
PAH
Treprostinil
Mylan Launches First Adcirca Generic, Stock Moves Up
Market Realist
Mon, 08/13/18 - 05:56 pm
Mylan
tadalafil
generics
PAH
Adcirca
United Therapeutics
Medtronic wins FDA nod to deliver PAH therapy with implantable pump
Drug Delivery Business News
Tue, 07/31/18 - 09:57 am
Medtronic
FDA
drug delivery
United Therapeutics
PAH
Remodulin
devices
SynchroMed II
GSK-backed Liquidia takes a seat at the IPO table, looking for a $57.5M stake to take on United Therapeutics
Endpoints
Mon, 07/2/18 - 09:35 am
Liquidia
IPOs
PAH
United Therapeutics
Tyvaso
United Therapeutics pays $210M to resolve kickback probe
BioPharma Dive
Thu, 12/21/17 - 09:53 am
United Therapeutics
kickbacks
DOJ
False Claims Act
Gilead Could Be Making An Acquisition — But It's Not What You Think
Investors Business Daily
Fri, 08/4/17 - 11:56 am
Gilead Sciences
M&A
United Therapeutics
GSK
Novartis
United Therapeutics (UTHR) Incurs Loss in Q2, Sales Top
Yahoo/Zacks.com
Sun, 07/30/17 - 09:40 am
United Therapeutics
earnings
How Is United Therapeutics’ Remodulin Positioned in 2017?
Market Realist
Mon, 07/3/17 - 09:46 am
United Therapeutics
Remodulin
PAH
pulmonary arterial hypertension
The 3 Most Profit-Friendly Biotech Stocks
Motley Fool
Tue, 12/13/16 - 10:23 am
biotech
biotech stocks
United Therapeutics
Gilead Sciences
Biogen
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Motley Fool
Sun, 11/20/16 - 05:37 pm
Medicare
H.P. Acthar Gel
Mallinckrodt
Remodulin
United Therapeutics
Tyvaso
Provenge
Valeant Pharmaceuticals
Gilead Sciences
Harvoni
United Therapeutics sees stepped-up competition and says it's 'a good thing'
Bizjournals.com
Tue, 03/1/16 - 10:59 pm
United Therapeutics
PAH
pulmonary arterial hypertension
Drug Firms Buy Pricey Vouchers to Speed Products to Market
WSJ Online
Tue, 10/20/15 - 09:52 am
review vouchers
United Therapeutics
FDA
AbbVie
Did AbbVie Just Make an Incredibly Brilliant Decision?
Motley Fool
Fri, 08/21/15 - 09:31 am
AbbVie
priority review
review vouchers
United Therapeutics
AbbVie Inc May Use Priority Voucher To Gain Lymphoma Lead Over Roche
Bidness, ETC
Thu, 08/20/15 - 11:53 am
AbbVie
priority review
Roche
CLL
chronic lymphocytic leukemia
United Therapeutics
AbbVie buys special review voucher for $350 mln
Yahoo/Reuters
Wed, 08/19/15 - 12:25 pm
AbbVie
priority review
review vouchers
United Therapeutics

Pages